Previous 10 | Next 10 |
Gainers: Cellectar Biosciences (NASDAQ: CLRB ) +7% . More news on: Cellectar Biosciences, Inc., INSYS Therapeutics, Inc., Soliton, Inc., Healthcare stocks news, Stocks on the move, Read more ...
INSYS Therapeutics (NASDAQ: INSY ) -51% on potential bankruptcy . More news on: INSYS Therapeutics, Inc., Genetic Technologies Limited, Minerva Neurosciences, Inc., Stocks on the move, Read more ...
Buckling under the pressure of a litany of lawsuits over its role in the U.S. opioid crisis, INSYS Therapeutics (NASDAQ: INSY ) warns that it may face a bankruptcy filing if it fails to complete a final settlement with the Department of Justice enabling it to collateralize the payments. ...
Insys Therapeutics (NASDAQ: INSY ): Q1 Non-GAAP EPS of -$0.55 misses by $0.32 ; GAAP EPS of -$1.66 misses by $1.43 . Revenue of $7.6M (-68.2% Y/Y) misses by $7.1M . Press Release More news on: INSYS Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news,
Company Continues to Execute Against Pipeline-Focused Strategy New Drug Application Submitted for Proprietary Naloxone Nasal Spray Formulation Company Provides Liquidity Update PHOENIX, May 10, 2019 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ: INSY), a leader in the d...
Today's Top Stories: It’s jobs day; Fedspeak coming up; and IPO watch. If you are interested in listening to Wall Street Breakfast to start your day, look for us in the following places: iTunes (find all Seeking Alpha Podcasts here ) Stitcher SoundCloud Googl...
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha , iTunes , Stitcher and Spotify (click the highlighted links). Dow futures are up 75 points , with S&P 500 and Nasdaq futures ahead by 0.3% and 0.5% , respectiv...
A jury in a Boston federal court has found INSYS Therapeutics ( INSY -2.1% ) founder John Kapoor and four other executives guilty of racketeering in a bribery and kickback scheme to doctors aimed at driving prescription volume for the painkiller fentanyl. More news on: INSYS Therapeuti...
Laurence Doud III, former CEO of Rochester Drug Co-Operative, was indicted yesterday by a Manhattan federal grand jury on charges of narcotics conspiracy and conspiracy to defraud the Drug Enforcement Administration (DEA) related to the distribution of "tens of millions" of opioid painkill...
The U.S. Depart of Justice has charged 60 people , including 31 physicians, with illegally prescribing and distributing opioid painkillers. The DOJ claims that the group, which includes 53 medical professionals, are tied to ~350K prescriptions and 32M pills. More news on: Endo Internation...
News, Short Squeeze, Breakout and More Instantly...
Insys Therapeutics Inc. Company Name:
INSY Stock Symbol:
NASDAQ Market:
Insys Therapeutics Inc. Website:
GD Entertainment and Technology’s (OTC: GDET ) Anil Idnani, CEO, will discuss the company’s 2020 outlook when he is interviewed by Stock Market Podcast. He will focus on GDET’s new customizable, prepaid ‘Dream Card’ and also the marketing of its CBD produc...
GD Entertainment and Technology (OTC: GDET ) announces today (June 15, 2020) that Anil Idnani, CEO,will be interviewed by Stock Market Podcast and offer a review of the company’s marketing growth and 2020 outlook. The company is focusing on both its re-introduced customizable, ...
Reinforcing the strength of CBD sales, website 420 Intel reported that sales of CBD hit $103 million for the month of May — the state’s first $100 million-plus month — representing a 15% jump over April and a 60% YOY spike from May last year. It was the third straight mo...